半胱氨酰白三烯受体拮抗剂在Guidelines中地位.pptVIP

Figure 3. Algorithm of preventive pharmacologic treatment for asthma in children 2 years of age Regular controller therapy. The main goal of regular controller therapy should be to reduce bronchial inflammation. 常规控制剂治疗的主要目标是减少气道炎症 LTRA? An alternative first-line treatment for persistent asthma. 持续性哮喘可选的一线治疗? Evidence supports use of oral montelukast as an initial controller therapy for mild asthma in children (153), as it provides bronchoprotection (154), and reduces airway inflammation as measured by nitric oxide levels in some preschool children with allergic asthma (155, 156). 有证据显示口服孟鲁